A claims analysis of over 200,000 adults with type 2 diabetes shown at EASD 2026 found the gap. Outside doctors note it shows association only and may reflect adherence.
Recap by typeshit. Full story at Healthline.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
STAT reports from a peptide medicine conference where stem cell entrepreneur Chuck Meeker predicted FDA roundtables before year end. The FDA declined to comment.
Prosecutors say the fake pens came from China and hit over 150 pharmacies and businesses. One defendant was extradited from Italy, and each faces up to 71 years if convicted.
Loading…